Family Medicine Doctors in Mt Vernon, TX Accepting Medicare
2 Family Medicine doctors found. Showing 1 - 2
 Dr. Mark J Hamilton, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 500 Highway 37 S, Mt Vernon, TX 75457 Phone: 903-537-8000 |
Jean Woel Latortue, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 506 Hwy 37 S, Mt Vernon, TX 75457 Phone: 903-537-8222 Fax: 903-537-8223 |
News Archive
Brits told to get off their bums and exercise!
A new survey of Brits has found that most people are so unwilling to exercise that even the prospect of a heart attack is not enough to persuade them.
St. Jude Medical reports net sales of $1.203 billion in fourth-quarter of 2009
St. Jude Medical, Inc. today reported sales and net earnings for the fourth quarter and year ended Jan. 2, 2010.
EKF Diagnostics to exhibit new STAT-Site WB β-ketone and glucose handheld analyzer at Medica 2021
EKF Diagnostics, the global in vitro diagnostics company, announces that it will be exhibiting live & in person at Medica 2021 (Hall 3 Stand B71) for the first time in mainland Europe in two years.
Discovery of new angiogenesis protein - possible cancer drug target
To grow and spread, tumors need new blood vessels, a process called angiogenesis. One growth factor that causes angiogenesis has been identified - vascular endothelial growth factor or VEGF - and drugs to inhibit VEGF are already in use. But not all tumors respond to the therapy initially or over the long term. Thus new growth factors need to be identified to aid in developing the next generation of angiogenesis inhibitors.
GOG to initiate combination elesclomol-paclitaxel Phase 2 clinical trial for ovarian cancer
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the Gynecologic Oncology Group (GOG) will initiate a Phase 2 clinical trial of elesclomol in combination with paclitaxel for the treatment of persistent or recurrent ovarian, fallopian tube or primary peritoneal cancer.
› Verified 2 days ago